Shattuck Labs Inc Ordinary Shares STTK
News
Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Shattuck Labs Announces Two Poster Presentations at UEG Week 2026
Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development
Shattuck Labs Announces Participation in Upcoming September Investor Conferences
